Please login to the form below
Average (mean) Salaries for 2005 (£000's)
Salaries
|
Job Title |
2005 |
|
Directors |
|
|
Medical |
£103.7 |
|
Personnel/HR director |
£92.5 |
|
Marketing |
£86.1 |
|
Business unit |
£85.8 |
|
PR communications director |
£84.5 |
|
Finance |
£82.5 |
|
Commercial |
£77.3 |
|
Sales |
£75.8 |
|
Business intelligence/market research |
£60.8 |
|
Department Heads |
|
|
Head of Commercial |
£72.9 |
|
Head of Marketing/manager |
£69.2 |
|
Head of Sales |
£66.7 |
|
Head of Finance |
£65.4 |
|
Head of Medical |
£65 |
|
Head of PR & Communications |
£59.2 |
|
Group/Senior Managers |
|
|
Business unit manager |
£65.4 |
|
Group training manager |
£58.7 |
|
Group product manager |
£57.5 |
|
Regional sales manager |
£54.5 |
|
Market research/BI manager |
£52.5 |
|
Senior product manager |
£49.9 |
|
Senior/group personnel manager |
£47.5 |
|
Product manager |
£45 |
Share
Related Hub content
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- How an AI algorithm might save your life
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
